The program for the 2012 OpenClinica Global Conference is now available online (see it here). This year’s program features lots of useful content–key themes include:
- Mobile (including mobile data collection, integration with mobile applications, etc.)
- Integration/Interoperability (including web services, randomization, and more)
- Using OpenClinica with SAS (perspectives, methods, and best practices)
- Tutorials (including study build, installation/troubleshooting, data mining, performance management, and several other topics)
- Case studies (including FISMA security, OpenClinica’s usage in the largest clinical research network in the world)
- …and more!
The event also features hands-on exhibits demonstrating OpenClinica-related technologies. Finally, we are thrilled to have Dr. Tomasz Sablinksi deliver this year’s keynote address as he proposes a thought-provoking new “open source” model for clinical development.
The conference is April 22-23 in Boston. Space is limited so be sure to register today! And don’t forget to sign-up for post conference, system admin, developer, and user training!
– Ben Baumann
Could the principles of open source and open innovation transform the future of clinical research? Come hear thought leader and innovator Dr. Tomasz Sablinski deliver the keynote presentation titled “Breaking Barriers: Forging a New Model for Clinical Development” at the 2012 OpenClinica Conference on April 23rd in Boston.
The world has shown that it is possible to harness the power of crowds to deliver incredibly successful innovation and services (think Facebook, Wikipedia, Linux). However, this style of innovation is relatively absent within the domain of clinical research. Sablinski believes the time may be ripe to borrow from the principles of open source and telemedicine in order to create a new, more effective model for clinical development.
Dr. Sablinski’s ideas have profound implications. However, while bold and thought provoking, they are more than academic. He puts his money where his mouth is–Sablinski’s start-up company, Transparency Life Sciences, has set out to increase the efficiency of clinical development leveraging open principles that turn much of the current way of thinking on its head.
Dr. Sablisnki’s assessments of the current state of clinical development are based on over 30 years in the field, as a practicing physician, basic researcher, drug developer, investor, and now, entrepreneur. He has served as a researcher at Harvard Medical School, a Medical Director at Parexel, VP of Clinical Development at Novartis, and Head of Development and Managing Director at private equity firm Celtic Therapeutics.
We look forward to hosting Dr. Sablinski at this year’s OpenClinica Global Conference!
– Ben Baumann
Chair, OpenClinica Conference Committee